• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

缺血后处理和/或卡托普利对正常血压和高血压大鼠心脏的影响。

Effects of a protocol of ischemic postconditioning and/or captopril in hearts of normotensive and hypertensive rats.

机构信息

Dipartimento di Scienze Cliniche e Biologiche, dell'Università di Torino, Regione Gonzole 10, 10043 Orbassano (TO), Italy.

出版信息

Basic Res Cardiol. 2010 Mar;105(2):181-92. doi: 10.1007/s00395-009-0075-6. Epub 2009 Dec 13.

DOI:10.1007/s00395-009-0075-6
PMID:20012872
Abstract

Brief periods (a few seconds) of cyclic coronary occlusions applied early in reperfusion induce a cardioprotection against infarct size, called postconditioning (PostC) in which B(2)-bradykinin receptors play a pivotal role. Since angiotensin-converting enzyme (ACE) inhibitors reduce degradation of kinins, we studied the effects of PostC on infarct size and postischemic myocardial dysfunction in both normotensive (WKY) and spontaneously hypertensive rats (SHR) acutely or chronically treated with the ACE inhibitor Captopril. Isolated hearts from SHR and WKY rats were subjected to the following protocols: (a) ischemia for 30- and 120-min reperfusion (I/R); (b) I/R + PostC protocol (5-cycles 10-s I/R); (c) pretreatment with Captopril for 4-weeks before to subject the hearts to I/R with or without PostC maneuvers. Some SHR hearts were treated with Captopril during the 20- or 40-min early reperfusion with or without PostC maneuvers. Cardiac function was assessed in vivo with echocardiography. Left ventricular pressure and infarct size were measured ex vivo. Chronic Captopril significantly reduced left ventricular hypertrophy in SHR, and reduced infarct size in both WKY and SHR hearts. PostC maneuvers significantly reduced infarct size in WKY, but not in SHR hearts. Yet, PostC slightly improved postischemic systolic function in untreated SHR. Captopril given in reperfusion was unable to limit I/R injury in SHR hearts. Data show that PostC protection against infarct size is blunted in SHR and that PostC is unable to add its protective effect to those of chronic Captopril, which per se reduces cardiac hypertrophy and heart susceptibility to I/R insult.

摘要

短暂的(几秒钟)循环性冠状动脉闭塞应用于再灌注早期可诱导针对梗死面积的心脏保护作用,称为后处理(PostC),其中 B(2)-缓激肽受体发挥关键作用。由于血管紧张素转换酶(ACE)抑制剂可减少激肽的降解,我们研究了后处理对急性或慢性用 ACE 抑制剂卡托普利治疗的正常血压(WKY)和自发性高血压大鼠(SHR)的梗死面积和缺血后心肌功能障碍的影响。来自 SHR 和 WKY 大鼠的离体心脏接受了以下方案的处理:(a)缺血 30 分钟和 120 分钟再灌注(I/R);(b)I/R + PostC 方案(5 个循环 10 秒 I/R);(c)在将心脏暴露于 I/R 之前用卡托普利预处理 4 周,无论是否进行 PostC 操作。一些 SHR 心脏在 20 分钟或 40 分钟早期再灌注期间用或不用 PostC 操作用卡托普利处理。通过超声心动图在体内评估心脏功能。在体测量左心室压力和梗死面积。慢性卡托普利显著降低 SHR 的左心室肥厚,并降低 WKY 和 SHR 心脏的梗死面积。PostC 操作显著降低了 WKY 心脏的梗死面积,但对 SHR 心脏没有影响。然而,PostC 略微改善了未经处理的 SHR 的缺血后收缩功能。在 SHR 心脏中,再灌注时给予卡托普利无法限制 I/R 损伤。数据表明,PostC 对梗死面积的保护作用在 SHR 中减弱,PostC 无法将其保护作用添加到慢性卡托普利的作用中,慢性卡托普利本身可降低心脏肥大和对 I/R 损伤的敏感性。

相似文献

1
Effects of a protocol of ischemic postconditioning and/or captopril in hearts of normotensive and hypertensive rats.缺血后处理和/或卡托普利对正常血压和高血压大鼠心脏的影响。
Basic Res Cardiol. 2010 Mar;105(2):181-92. doi: 10.1007/s00395-009-0075-6. Epub 2009 Dec 13.
2
Increased myocardial vulnerability to ischemia-reperfusion injury in the presence of left ventricular hypertrophy.左心室肥厚情况下心肌对缺血-再灌注损伤的易感性增加。
J Hypertens. 2016 Mar;34(3):513-23; discussion 523. doi: 10.1097/HJH.0000000000000826.
3
Ischemia/reperfusion injury is increased and cardioprotection by a postconditioning protocol is lost as cardiac hypertrophy develops in nandrolone treated rats.去氢表雄酮处理的大鼠发生心肌肥厚时,缺血/再灌注损伤增加,而预先处理方案的心脏保护作用丧失。
Basic Res Cardiol. 2011 May;106(3):409-20. doi: 10.1007/s00395-010-0143-y. Epub 2010 Dec 21.
4
Ischemic preconditioning is lost in aging hypertensive rat heart: independent effects of aging and longstanding hypertension.缺血预处理在衰老高血压大鼠心脏中丧失:衰老和长期高血压的独立作用。
Exp Gerontol. 2007 Aug;42(8):807-14. doi: 10.1016/j.exger.2007.04.005. Epub 2007 Apr 24.
5
Helium-induced cardioprotection of healthy and hypertensive rat myocardium in vivo.体内氦气诱导健康和高血压大鼠心肌的心脏保护作用。
Eur J Pharmacol. 2012 Jun 5;684(1-3):125-31. doi: 10.1016/j.ejphar.2012.03.045. Epub 2012 Apr 3.
6
Intermittent adenosine at the beginning of reperfusion does not trigger cardioprotection.再灌注开始时给予间歇性腺苷不会引发心脏保护作用。
J Surg Res. 2009 May 15;153(2):231-8. doi: 10.1016/j.jss.2008.02.070. Epub 2008 Apr 8.
7
Synergistic effects against post-ischemic cardiac dysfunction by sub-chronic nandrolone pretreatment and postconditioning: role of beta2-adrenoceptor.次慢性诺龙预处理和后适应对缺血后心脏功能障碍的协同作用:β2肾上腺素能受体的作用
J Physiol Pharmacol. 2008 Dec;59(4):645-59.
8
Protective effects of N-(2-mercaptopropionyl)-glycine against ischemia-reperfusion injury in hypertrophied hearts.N-(2-巯基丙酰基)-甘氨酸对肥厚心脏缺血再灌注损伤的保护作用。
Exp Mol Pathol. 2013 Feb;94(1):277-84. doi: 10.1016/j.yexmp.2012.07.004. Epub 2012 Jul 28.
9
pGlu-serpinin protects the normotensive and hypertensive heart from ischemic injury.焦谷氨酸-蛇床子素可保护正常血压和高血压心脏免受缺血性损伤。
J Endocrinol. 2015 Dec;227(3):167-178. doi: 10.1530/JOE-15-0199. Epub 2015 Sep 23.
10
Comparative effects of ischemic pre and postconditioning on ischemia-reperfusion injury in spontaneously hypertensive rats (SHR).缺血预处理和后处理对自发性高血压大鼠(SHR)缺血再灌注损伤的比较作用。
Mol Cell Biochem. 2007 Feb;296(1-2):45-51. doi: 10.1007/s11010-006-9296-2. Epub 2006 Aug 25.

引用本文的文献

1
Hypoxic Cardioprotection by New Antihypertensive Compounds in High Salt-Diet Hypertensive Rats: Glucose Transport Participation and Its Possible Pathway.新型抗高血压化合物在高盐饮食性高血压大鼠中的低氧心肌保护作用:葡萄糖转运的参与及其可能途径。
Int J Mol Sci. 2024 Aug 13;25(16):8812. doi: 10.3390/ijms25168812.
2
High-Density Lipoprotein Signaling via Sphingosine-1-Phosphate Receptors Safeguards Spontaneously Hypertensive Rats against Myocardial Ischemia/Reperfusion Injury.通过1-磷酸鞘氨醇受体的高密度脂蛋白信号传导可保护自发性高血压大鼠免受心肌缺血/再灌注损伤。
Pharmaceutics. 2024 Apr 3;16(4):497. doi: 10.3390/pharmaceutics16040497.
3
Modulation of Angiotensin-II and Angiotensin 1-7 Levels Influences Cardiac Function in Myocardial Ischemia-reperfusion Injury.
血管紧张素-II和血管紧张素1-7水平的调节对心肌缺血再灌注损伤中的心脏功能产生影响。
Curr Drug Res Rev. 2025;17(1):102-112. doi: 10.2174/0125899775280160240122065607.
4
Dexmedetomidine as a cardioprotective drug: a narrative review.右美托咪定作为一种心脏保护药物:叙事性综述。
J Anesth. 2023 Dec;37(6):961-970. doi: 10.1007/s00540-023-03261-w. Epub 2023 Sep 26.
5
Interaction of Cardiovascular Nonmodifiable Risk Factors, Comorbidities and Comedications With Ischemia/Reperfusion Injury and Cardioprotection by Pharmacological Treatments and Ischemic Conditioning.心血管不可变风险因素、合并症和合并用药与缺血/再灌注损伤的相互作用,以及药物治疗和缺血预处理的心脏保护作用。
Pharmacol Rev. 2023 Jan;75(1):159-216. doi: 10.1124/pharmrev.121.000348. Epub 2022 Dec 8.
6
The protective effects of phosphoserine aminotransferase 1 (PSAT1) against hepatic ischemia-reperfusion injury.磷酸丝氨酸氨基转移酶1(PSAT1)对肝脏缺血再灌注损伤的保护作用。
J Cell Commun Signal. 2023 Sep;17(3):851-862. doi: 10.1007/s12079-023-00727-0. Epub 2023 Feb 6.
7
Preclinical multi-target strategies for myocardial ischemia-reperfusion injury.心肌缺血再灌注损伤的临床前多靶点策略
Front Cardiovasc Med. 2022 Aug 22;9:967115. doi: 10.3389/fcvm.2022.967115. eCollection 2022.
8
Ischemic Postconditioning Attenuates Bilateral Renal Ischemia-induced Cognitive Impairments.缺血后处理减轻双侧肾缺血诱导的认知障碍。
Basic Clin Neurosci. 2021 Nov-Dec;12(6):789-804. doi: 10.32598/bcn.2021.1941.1. Epub 2021 Nov 1.
9
High Density Lipoprotein Reduces Blood Pressure and Protects Spontaneously Hypertensive Rats Against Myocardial Ischemia-Reperfusion Injury in an SR-BI Dependent Manner.高密度脂蛋白以SR-BI依赖的方式降低血压并保护自发性高血压大鼠免受心肌缺血再灌注损伤。
Front Cardiovasc Med. 2022 Mar 21;9:825310. doi: 10.3389/fcvm.2022.825310. eCollection 2022.
10
Antihypertensive activity of oleanolic acid is mediated via downregulation of secretory phospholipase A2 and fatty acid synthase in spontaneously hypertensive rats.齐墩果酸的降压活性是通过下调自发性高血压大鼠分泌型磷脂酶 A2 和脂肪酸合酶来实现的。
Int J Mol Med. 2020 Dec;46(6):2019-2034. doi: 10.3892/ijmm.2020.4744. Epub 2020 Sep 30.